Form 4 for IOVA IOVANCE BIOTHERAPEUTICS, INC.
Accepted 2024-11-14 00:00:00 ET · period of report 2024-11-12 · accession 0001104659-24-119195 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-14 | 2024-11-12 | IOVA | Maynard Ryan D | Dir | S - Sale+OE | $10.06 | -50.0K | 7,500 | -87% | -$503.0K |
| D | 2024-11-14 | 2024-11-12 | IOVA | Maynard Ryan D | Dir | M - OptEx | $7.45 | +50.0K | 57.5K | +667% | +$372.5K |
| D | 2024-11-14 | 2024-11-12 | IOVA | Maynard Ryan D | Dir | M - OptEx | $0.00 | -50.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-12 | S | D | 50,000 | $10.06 | 7,500 | D | — | — | (F3) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $10.05 and $10.105. |
| 2 | Common | Common Stock | 2024-11-12 | M | A | 50,000 | $7.45 | 57,500 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-11-12 | M | D | 50,000 | $0.00 | 0 | D | $7.45 · 2016-02-16 to 2025-02-15 | 50,000 Common Stock | (F5) Such aggregate number reflects the remainder of such stock options granted on February 16, 2015, but does not include any other stock options held by such Reporting Person. (F4) These options became exercisable in four equal quarterly installments of 12,500 each following the date of grant, which was February 16, 2015. |